Brief Title
Effect of Fee on Attendance in Cervical Cancer Screening
Official Title
Effect of Fee on Attendance in Cervical Cancer Screening-results From ScreenFee a Swedish Population Based Randomised Trial
Brief Summary
Several reasons can explain non-attendance in cervical cancer screening. In low resource
settings the attendance is even lower. The effect of fee as contributing reason of non
attendance has not been studied before why the investigators decided to study this in a low
resource setting as a randomised trial.
Detailed Description
Non-attendance in the cervical cancer screening programme is the most important factors why
Swedish women contract the disease. Low attendance rate is observed in districts with low
socioeconomic resources. Several reasons can explain this, including the existence of a fee.
A low attendance rate in low resource districts is also noticed in Gothenburg, Sweden. After
multiple interventions the coverage has slightly increased. None of the interventions
included the aspect of the fee. The investigators decided to study the effect of fee
abolishment in a randomized control trial emanating from the regular cervical
cancer-screening program. Method: Randomized Control Trial (RCT). Women in low resource areas
of Gothenburg, due for screening, January-July 2013, were randomised to receive an offer of a
free test or receiving the regular invitation stating the regular fee of 100 Swedish kronor
(SEK) (≈11 €). Power calculation has shown 80 % power to detect an increase in participation
of 20% at 1972 participants.
Study Type
Interventional
Primary Outcome
Difference in attendance
Secondary Outcome
Differences in attendance stratified for age groups, home districts and previous pap smear history.
Condition
Cervical Dysplasia
Intervention
Screening without fee
Study Arms / Comparison Groups
Intervention and control
Description: Intervention arm: screening without fee.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
3124
Start Date
January 2013
Completion Date
July 2013
Primary Completion Date
July 2013
Eligibility Criteria
Inclusion Criteria:
- All women in the designated geographical area, consecutively enrolled in planned
screening according to standard routine. I.e women are invited if they are between 23
and 60 years of age and don't have a pap smear registered the last three or five years
according to age.
Exclusion Criteria:
- None
Gender
Female
Ages
23 Years - 60 Years
Accepts Healthy Volunteers
No
Contacts
Björn Strander, PhD, ,
Administrative Informations
NCT ID
NCT02378324
Organization ID
ScreenFee
Responsible Party
Sponsor
Study Sponsor
Göteborg University
Study Sponsor
Björn Strander, PhD, Study Director, Regional Cancer Center West
Verification Date
February 2015